Bridgewest Ventures is a venture capital and incubator firm headquartered in Auckland, New Zealand. It funds and supports early-stage companies across biotechnology, agtech, pharmaceuticals, unmanned aerial vehicles, Internet of Things, semiconductors, artificial intelligence, software development, drug discovery, life sciences, and health tech, seeking opportunities with global commercialization.
MACSO aims to give AI the capacity to mimic human senses in order to prevent catastrophes from occurring. Their initial application employs AI and acoustic sensors to identify respiratory sickness in animals on commercial livestock farms early.
MACSO is headquartered in Auckland, New Zealand and was founded in 2021.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.